Head, Clinical Pharmacology & Early Clinical Development
Takeda Development Center Americas, Inc., Cambridge, MA, USA
Cambridge, Massachusetts, United States
Dr. Zhaoyang (Megan) Li, PhD, is currently the Head of Global Clinical Pharmacology & Early Clinical Development in Plasma Derived Therapies Business Unit at Takeda Pharmaceuticals. Her research focuses on clinical development of plasma-derived therapies for various diseases including priamry immune deficiencies, neuro-autoimmune diseases, hematology, pulmonary and other rare diseases. She has been working in the biopharmaceutical industry for nearly 25 years.
Tuesday, June 27, 2023
18:30 – 19:30 ET